Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining -0.17% today. In the last week its performance is -1.30%, and -3.91% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 171.75, so today’s gain of -0.17% is a significant step towards its target price. The GAP today is therefore -0.55%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 29953.98, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 98.70%.

At the current price of 133.44, it has a dividend yield of *TBA, and its target price is 171.75. This is with a profit margin of 3.20%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 338.41, as well as a forward P/E of 22.33.

With a current EPS of 0.4, and a forecasted EPS growth for next year at 27.78%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.28%.

Performance for the year is -30.02%. Since its IPO date on 2/28/1996, the total performance to date is -29.92%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 1096222, while its average volume is 2003.95. Whilst the total gain today was -0.17%, it did have a day high of -15.02%.

Volatility for this week has been at 2.00%, and 2.60% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 20.69%, while the 52-week-high has reached -31.02%.

Looking at its return of investments, which is 1.60%, and its return on assets is 0.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 21.70%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.39, and has a current ratio of 3.6 and 3.1 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 18.51, and the P/S is 10.62, along with a P/B of 3.65. Meanwhile it has a p/cash of 25.38.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment